Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68GA-DOTA-dPNE PET/CT Imaging in Breast Cancer
NCT06411678Phase 1Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2024
- Primary completion
- Dec 2027
- Modality
- Antibody-Radionuclide Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-dPNE in breast cancer, sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic performance of 68Ga-DOTA-dPNE PET at 1 year. Started May 2024; status: recruiting.
02
Drugs
68Ga-dPNE
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06411678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411678.